This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1977.
Company Filing History:
Years Active: 1977
Title: Eike Druckrey: Innovator in Pharmaceuticals
Introduction: Eike Druckrey, located in Rossert, Germany, is a notable inventor recognized for his contributions to the pharmaceutical industry. With one patent to his name, his work focuses on developing compounds that enhance medical treatments.
Latest Patents: Druckrey's significant patent is focused on benzylamine derivatives, specifically N-Cycloalkyl-benzylamine derivatives. This patent details a chemical formula that includes various components such as R1 representing hydrogen or lower alkyl of 1 to 4 carbon atoms, and R2 which signifies a cycloalkyl radical that may contain alkyl substitution and hydrocarbon bridges. These innovations have been disclosed for their diuretic and saluretic activity, indicating their potential therapeutic benefits.
Career Highlights: Eike Druckrey works with Hoechst Aktiengesellschaft, a major player in the pharmaceutical sector, known for its commitment to research and innovation. His patent emphasizes his role in advancing medicinal chemistry and showcases his expertise in developing derivatives that can lead to improved health outcomes.
Collaborations: Throughout his career, Druckrey has worked alongside esteemed colleagues, including Bernd Knabe and Hans-Jochen Lang. Their collaborations highlight the importance of teamwork in scientific innovation, contributing to advancements in drug development and pharmacology.
Conclusion: Eike Druckrey's innovations in benzylamine derivatives represent a significant stride in pharmaceutical research. His patent not only showcases his ingenuity as an inventor but also reflects the collaborative spirit of his work at Hoechst Aktiengesellschaft, culminating in contributions that may enhance therapeutic practices in medicine.